|
Aug 5
|
Update on Knight Therapeutics: Applies for Mexican Approval to Market Parkinson's Disease Treatment
|
|
Aug 5
|
Knight Therapeutics Announces Regulatory Submission of CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Mexico
|
|
Aug 5
|
Knight Therapeutics, Incyte Expand Relationship to Distribute Additional Medicines in Latin America
|
|
Aug 4
|
Knight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America
|
|
Aug 1
|
Notice of Knight Therapeutics' Second Quarter 2025 Results Conference Call
|
|
Jul 31
|
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil
|
|
Jul 24
|
TSX Growth Companies With High Insider Ownership For July 2025
|
|
Jul 18
|
Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada
|
|
Jun 25
|
3 TSX Growth Companies With Insider Ownership As High As 22%
|
|
May 14
|
Knight Therapeutics First Quarter 2025 Earnings: EPS Beats Expectations
|
|
May 13
|
Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City
|
|
May 1
|
Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call
|
|
Apr 29
|
Knight to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
|
|
Apr 28
|
TSX Growth Companies With High Insider Ownership April 2025
|
|
Oct 9
|
Knight Therapeutics Inc (KHTRF) Q2 2024 Earnings Call Highlights: Record Revenues and Strategic ...
|
|
May 12
|
Knight Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 9
|
Knight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1
|
|
May 9
|
Knight Therapeutics Reports First Quarter 2024 Results
|
|
May 9
|
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
|
|
May 8
|
Knight Therapeutics Inc. announces voting results from the Annual General Meeting
|